BookGeorg Wick, Cecilia Grundtman, [editors].
Contents:
Ch. 1. Historical reflections on the inflammatory aspects of atherosclerosis
Ch. 2. Morphology of atherosclerotic lesions
Ch. 3. Clinical manifestations of atherosclerosis
Ch. 4. Intra-aortic hematopoietic cells
Ch. 5. The vascular-associated lymphoid tissue (VALT)
Ch. 6. Vascular endothelial cells as immunological targets in atherosclerosis
Ch. 7. The role of adhesion molecules and intimal dendritic cells in the initiation of atherosclerosis
Ch. 8. Animal models of atherosclerosis
Ch. 9. A Darwinian-evolutionary concept for atherogenesis: the role of immunity to HSP60
Ch. 10. Mediators of vascular inflammation
Ch. 11. Pentraxins and atherosclerosis
Ch. 12. Interleukin-33 and atherosclerosis
Ch. 13. Proteomics of atherosclerosis
Ch. 14. Adipokines, inflammation, and atherosclerosis
Ch. 15. Natural antibodies and atherosclerosis
Ch. 16. NK/NKT cells and atherosclerosis
Ch. 17. Macrophages and atherosclerosis
Ch. 18. Host pattern recognition receptors (toll-like receptors, RIG-I-Like receptors, NOD-like receptors) and atherosclerosis
Ch. 19. Humoral antibodies
Ch. 20. Adaptive T Cell immunity
Ch. 21. Immunity to low-density lipoprotein
Ch. 22. Extracellular matrix and smooth muscle cells
Ch. 23. The role of infection in atherosclerosis and in plaque stability
Ch. 24. Inflammatory biomarkers
Ch. 25. Atherosclerosis in rheumatic diseases
Ch. 26. Anti-inflammatory therapeutic approaches
Ch. 27. Vaccination against atherosclerosis
Ch. 28. Endocrinological aspects of atherosclerosis
Ch. 29. Imaging of atherosclerosis
Ch. 30. Future directions of atherosclerosis research and translation into clinical application
Ch. 31. Controversies and open questions
Index.